Combined image interpretation of computed tomography and hybrid PET in head and neck cancer

NuklearMedizin

Volumn 41, Issue 1, 2002, Pages 14-21

  Zimny, Michael ^a   Wildberger, J E ^a   Cremerius, U ^a   DiMartino, E ^a   Jaenicke, S ^a   Nowak, B ^a   Bull U ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

CT; Fluorodeoxyglucose; Head and neck tumours; Hybrid PET

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HEAD AND NECK CANCER; HUMAN; IMAGE ANALYSIS; POSITRON EMISSION TOMOGRAPHY;

EID: 0036183964     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623998     Document Type: Article

References (33)

1. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
2. Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses
3. A combined PET/CT scanner for clinical oncology
4. Kombinationssysteme für SPECT, Koinzidenz, PET und CT
5. Value of attenuation correction and image fusion for interpretation of FDG images using an integrated hybrid camera with X-ray based attenuation maps in patients with known or suspected malignancies
6. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography
7. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck
8. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck
9. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer
10. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation
11. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting
12. Value of spiral CT in the staging of carcinomas of the oral cavity, the oropharynx and hypopharynx
13. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas
14. Oropharynx, oral cavity, floor of the mouth: CT and MRI
15. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
16. PET scanning in head and neck oncology: A review
17. A new approach for testing the significance of differences between ROC curves measured from correlated data
18. Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumours
19. Positron emission tomography in the evaluation of the NO neck
20. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI
21. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer
22. 18FDG-PET for the assessment of primary head and neck tumours: Clinical, computed tomography, and histopathological correlation in 38 patients
23. Computer coregistration of positron emission tomography and magnetic resonance images in head and neck cancer
24. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner
25. Paranasal sinuses and nasopharynx CT and MRI
26. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography
27. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: A pilot study
28. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography
29. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma
30. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images
31. Fluorine-18-fluorodeoxyglucose positron imaging in oncological patients gamma camera coincidence detection versus dedicated PET
32. Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in oncological patients: Effects of non-uniform attenuation correction on lesion detection
33. Einfluss von fourier-rebinning auf onkologische FDG-PET mit einer koinzidenzfähigen doppelkopfkamera (hybrid-PET)